These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19157062)

  • 1. Chemical induced alterations in p53 signaling.
    Högberg J; Silins I; Stenius U
    EXS; 2009; 99():181-208. PubMed ID: 19157062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the p53 family for cancer therapy: 'big brother' joins the fight.
    Bell HS; Ryan KM
    Cell Cycle; 2007 Aug; 6(16):1995-2000. PubMed ID: 17721076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances on mutant p53 research].
    Li DH; Zhang LQ; He FC
    Yi Chuan; 2008 Jun; 30(6):697-703. PubMed ID: 18550490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.
    Pant V; Quintás-Cardama A; Lozano G
    Blood; 2012 Dec; 120(26):5118-27. PubMed ID: 23018641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modeling of p53 signaling pathway based on S-system equations].
    Liu S; Tao C; Huang Z; Huang S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):505-10. PubMed ID: 20649007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functions of p53 in metabolism and invasion.
    Vousden KH
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):511-7. PubMed ID: 19442244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation.
    Pogribny IP; Muskhelishvili L; Tryndyak VP; Beland FA
    Toxicol Appl Pharmacol; 2009 Mar; 235(3):305-11. PubMed ID: 19167416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the interplay between JNK and p53-DRAM signalling pathways in the regulation of autophagy.
    Lorin S; Pierron G; Ryan KM; Codogno P; Djavaheri-Mergny M
    Autophagy; 2010 Jan; 6(1):153-4. PubMed ID: 19949306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways.
    Yu CL; Driggers P; Barrera-Hernandez G; Nunez SB; Segars JH; Cheng S
    Biochem Biophys Res Commun; 1997 Oct; 239(2):617-20. PubMed ID: 9344880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping genetic alterations in human cancer: the p53 mutation paradigm.
    Soussi T; Wiman KG
    Cancer Cell; 2007 Oct; 12(4):303-12. PubMed ID: 17936556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of p53 by specific agents in potential cancer therapy.
    Ho JW; Song JZ; Leung YK
    Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):131-5. PubMed ID: 15777220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of the Tumor Suppressors p53 and Rb in Actin Cytoskeleton Remodeling.
    Ebata T; Hirata H; Kawauchi K
    Biomed Res Int; 2016; 2016():9231057. PubMed ID: 28078303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
    Puca R; Nardinocchi L; Givol D; D'Orazi G
    Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
    French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
    Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway.
    Tanikawa C; Ri C; Kumar V; Nakamura Y; Matsuda K
    Mol Cancer Res; 2010 Jun; 8(6):855-63. PubMed ID: 20501644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts.
    Yih LH; Lee TC
    Cancer Res; 2000 Nov; 60(22):6346-52. PubMed ID: 11103796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the aromatic hydrocarbon receptor pathway is not sufficient for transcriptional repression of BRCA-1: requirements for metabolism of benzo[a]pyrene to 7r,8t-dihydroxy-9t,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
    Jeffy BD; Chirnomas RB; Chen EJ; Gudas JM; Romagnolo DF
    Cancer Res; 2002 Jan; 62(1):113-21. PubMed ID: 11782367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complexity of p53 modulation: emerging patterns from divergent signals.
    Giaccia AJ; Kastan MB
    Genes Dev; 1998 Oct; 12(19):2973-83. PubMed ID: 9765199
    [No Abstract]   [Full Text] [Related]  

  • 19. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage.
    Yoshida K; Miki Y
    Cancer Sci; 2010 Apr; 101(4):831-5. PubMed ID: 20132225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of human cancer.
    Hussain SP; Harris CC
    Recent Results Cancer Res; 1998; 154():22-36. PubMed ID: 10026991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.